The present study characterizes cellular calcium stores that are sensitive to norepinephrine and caffeine in arteries from deoxycorticosterone acetate hypertensive rats. Mesenteric arteries from normotensive and hypertensive rats were excised and cut into helical strips for isometric force recording. In calcium-free solution, phasic contractile responses to norepinephrine (5.9 x 10' to 5.9 x 10~* M), but not caffeine (0.3-30 mM), were greater in hypertensive arteries. D-600, a calcium channel blocker, or removal of the endothelium did not alter phasic contractions to norepinephrine or caffeine. In contrast, contractions to both norepinephrine and caffeine were inhibited by ryanodine, a drug that depletes calcium from intracellular stores. An inhibitor of phospholipase C (2-nitn>-4-carboxyphenyl jV,iV-diphenylcarbamate) attenuated contractions to norepinephrine but not those to caffeine. The augmented response to norepinephrine in hypertensive rats did not occur early after implantation of the mineralocorticoid, suggesting that this vascular change may not play a role in the development of high blood pressure in this experimental model. The augmented response to norepinephrine was reduced in mineralocorticoid-treated rats maintained on a low sodium diet, and these rats had blood pressures in the normotensive range. Because contractile responses to caffeine were not enhanced in arteries from hypertensive rats, we conclude that the cellular store for calcium is not enlarged compared with that in normotensive arteries. In contrast, the mobilization of calcium from cellular stores by norepinephrine is augmented in mineralocorticoid hypertension. This augmented response may be linked to altered phospholipase C activity and thus to an augmented action of inositol trisphosphate that releases calcium from intracellular sites. (Hypertension 1991;17:603-611) S everal recent studies 1 " 4 indicate that the release of calcium from intracellular storage sites is an important step in the activation of contraction in vascular smooth muscle. There is evidence that this calcium release is a response to elevated levels of inositol 1,4,5 -trisphosphate (IP 3 ), a product of hydrolysis of phosphatidylinositol 4,5-bisphosphate of the plasma membrane by phospholipase C. It has been proposed that alterations in the storage or release of calcium from intracellular sites may be an important cellular change contributing to increased vascular reactivity in hypertension. 7 Further, it has been documented that phospholipase C activity and the generation of second messengers (EP 3 and protein kinase C) involved in calcium translocation are altered in several models of hypertension.
S everal recent studies 1 " 4 indicate that the release of calcium from intracellular storage sites is an important step in the activation of contraction in vascular smooth muscle. There is evidence that this calcium release is a response to elevated levels of inositol 1,4,5 -trisphosphate (IP 3 ), a product of hydrolysis of phosphatidylinositol 4,5-bisphosphate of the plasma membrane by phospholipase C. 6 This sequence of events is initiated via receptor activation by certain hormones and neurotransmitters. 6 It has been proposed that alterations in the storage or release of calcium from intracellular sites may be an important cellular change contributing to increased vascular reactivity in hypertension. 7 Further, it has been documented that phospholipase C activity and the generation of second messengers (EP 3 and protein kinase C) involved in calcium translocation are altered in several models of hypertension. 5 - 7 The major objective of the current study was to characterize cellular calcium stores that are sensitive to norepinephrine in arteries from deoxycorticosterone acetate (DOCA) hypertensive rats. The actions of several pharmacological agents (e.g., ryanodine, caffeine, D-600) were studied in an effort to understand potential mechanisms that contribute to altered cellular handling of calcium in this animal model of hypertension. Experiments were performed to evaluate the time course of the vascular change during the development of high blood pressure and the sensitivity of the vascular response to dietary intake of salt.
uninephrectomy was performed while the rats were anesthetized, and Silastic without DOCA was implanted subcutaneously). All rats were maintained on standard laboratory rat chow and drinking water containing 1% NaG and 0.2% KC1. Experiments were performed after 6 days or 4-6 weeks of DOCA treatment. In one set of experiments, six DOCAtreated rats and six sham-treated rats were placed on a low sodium diet (i.e., low sodium chow and tap water) 4 weeks after implantation. The duration of the dietary manipulation was 2 weeks. Systolic blood pressures were determined by tail-cuff measurements (pneumatic pulse transducer, Narco Biosystems, Houston, Tex.) in the conscious rat.
On the day of an experiment, a DOCA-treated rat was paired with a sham-treated rat. Both rats were anesthetized with sodium pentobarbital, and the mesenteric arteries were excised and placed in cold physiological salt solution (PSS) (4°C) for storage. Excess fat and connective tissue were trimmed from the arteries, and the arteries were cut into helical strips (0.8x10 mm) under a dissecting microscope. The arterial segments were mounted vertically on a stainless steel holder in a tissue bath containing PSS. The upper ends of the arterial strips were connected to force transducers (model FT.03, Grass Instrument Co., Quincy, Mass.) and a passive force (500-650 mg) that allowed maximum contraction to norepinephrine (5.9 xlO" 6 M) was placed on each strip. In each experiment, an arterial strip from a DOCAtreated and a control rat were mounted in the same bath, assuring that tissue from both sources had identical stimuli. Before the start of the experiments, the strips were allowed to equilibrate for 2 hours in PSS. The bathing medium was maintained at 37°C and was aerated with a 95% Oz-5% CO 2 mixture. The pH of the solution was 7.2 and the composition (mmol/1) was as follows: NaCl 130, KC1 4.7, KH 2 PO 4 1.18, MgSO 4 -7H 2 O 1.17, NaHCO 3 14.9, CaNa 2 EDTA 0.026, CaCl 2 -H 2 O 1.6, and dextrose 5.5. Calcium-free buffer contained 1.0 mM EGTA and no added calcium.
A rubbing procedure was used to remove the endothelium from the vascular segments in six experiments. After preparation of the helical strips, the lumen surface of the segments was rubbed with a cotton swab. These strips were placed in the muscle bath along with paired strips that were not rubbed. The presence or absence of endothelium was functionally evaluated by relaxation to acetylcholine (10~7 M) after contraction in response to norepinephrine (5.9xlO" 8 M). Contractile responses to norepinephrine (5.9 xlO" 9 to 5.9xlO" 6 M) and caffeine (0.3-30 mM) in calcium-free solution after loading of a cellular store for calcium were investigated according to the method of Karaki et al. 8 The cellular stores were depleted and then loaded with calcium by placing the tissue in a known concentration of calcium (0.025-4.0 mM) for 5 minutes. After this loading procedure, the arterial segments were placed in calcium-free PSS (1.0 mM EGTA) for 1 minute and a contraction to norepinephrine or caffeine was obtained. These responses were normalized to the maximum contraction to norepinephrine in normal PSS (1.6 mM CaCl 2 ).
Drugs used in this study were norepinephrine (Levophed bitartrate, Breon Laboratories, New York), acetycholine (Miochol, Cooper Vision Pharmaceuticals, San German, Puerto Rico), caffeine (Sigma Chemical Co., St. Louis, Mo.), serotonin creatinine sulfate (Sigma), angiotensin II (Sigma), D-600 (Knoll Pharmaceutical Co., Whippany, N.J.), 2-nitro-4-carboxyphenyl Af.Af-diphenylcarbamate (NCDC) (Sigma), ryanodine (Calbiochem, La Jolla, Calif.), and DOCA (Sigma).
Data are reported as mean±SEM. An unpaired analysis (Student's t test) was used to compare observations between hypertensive and normotensive rat groups, whereas a paired analysis (f test) was used to compare responses in the same set of tissues. In all cases, the Bonferroni correction was applied to adjust for multiple comparisons. ED50 values (dose of agonist producing a half-maximal response) were determined after logit transformation of normalized dose-response curves. A value of /?<0.05 was regarded as statistically significant.
Results
The systolic blood pressures of DOCA-salt rats at 4-6 weeks after implantation (182±3 mm Hg) were significantly higher than those of sham-treated, normotensive rats (121 ±2 mm Hg). Figure 1 illustrates the format of the procedure used to evaluate the involvement of a cellular store of calcium that can be mobilized by norepinephrine or caffeine to produce contraction. Arterial strips from hypertensive and normotensive rats were made to contract to a maximal dose of norepinephrine (5.9xlO~6 M) in normal PSS containing 1.6 mM CaCl 2 . After the contractile response had reached a plateau (10 minutes), the strips were placed for 10 minutes in calcium-free PSS (1.0 mM EGTA) to deplete cellular calcium stores. This procedure produced complete depletion of calcium in the arterial segments since the addition of norepinephrine (5.9xlO" 6 M) or caffeine (30 mM) failed to produce a contraction. After this calcium depletion step, the arteries were loaded by placing them in PSS with a known concentration of calcium (0.025-4 mM) for 5 minutes. At the end of this loading period, the arterial strips were placed in calcium-free PSS (1.0 mM EGTA) for 1 minute and then norepinephrine (5.9xl0" 7 M, Figure 1A ) or caffeine (30 mM, Figure  IB ) was added to the muscle bath. The phasic contraction produced during the second treatment with calcium-free buffer was compared with the maximal contraction to norepinephrine in 1.6 mM CaCl 2 . Phasic contractile responses to norepinephrine (5.9xlO" 7 M, Figure 1A ) but not caffeine (30 mM, Figure IB ) in arteries from hypertensive rats were greater than those in arteries from normotensive rats. In arteries from both groups of rats, a Figure 2A shows the relation between norepinephrine concentration and phasic contractile responses in mesenteric arteries from DOCA hypertensive rats and sham-treated normotensive rats. The magnitudes of phasic contractions to norepinephrine were greater in arteries from hypertensive rats than normotensive values at all concentrations of the catecholamine. Vascular sensitivity to norepinephrine in arteries from hypertensive rats was increased compared with normotensive arteries as indicated by the shift in ED50 values to the left (DOCA, -log EDJO value=7.45±0. The magnitudes of phasic contractile responses to 5.9xlO~7 M) norepinephrine were dependent on the concentration of calcium (0.025-4 mM) in the PSS during the loading procedure. At calcium concentrations greater than 10~4 M, phasic contractions to 5.9xlO~7 M in arteries from hypertensive rats were greater than those in arteries from normotensive rats. EDso values for calcium in arteries from hypertensive rats (-log ED5o=3.63±O.O5; antilog=2.37xlO-4 M) were not statistically different from those in arteries from normotensive rats (-log ED5o=3.61±0.05; antilog=2.43xlO-4 M). The magnitude of the phasic contraction to norepinephrine (5.9x 10~4 M) also varied with the length of the loading period ( Figure 3A ). At all intervals in 2.0 mM CaCl 2 (1-40 minutes), phasic contractions to norepinephrine (in calcium-free PSS) in arteries from hypertensive rats were greater than those in arteries from normotensive rats. In contrast to the loading procedure, phasic contractions to norepinephrine (5xlO~7 M) at various intervals after the maximal response to norepinephrine in calcium-free buffer (first exposure before loading procedure) in arteries from hypertensive rats were not statistically different from normotensive values ( Figure 3B ).
In addition to norepinephrine and caffeine, three other agonists were tested with regard to their ability to mobilize calcium from cellular stores (Figure 4) . Phasic contractions to serotonin (10~6 M) and angiotensin II (5xlO~8 M) in mesenteric arteries from DOCA hypertensive rats were greater than those in arteries from normotensive rats. Depolarizing solution (100 mM KC1) did not cause contractions of arteries in calcium-free solution with 1.0 mM EGTA. Figure 5A shows the relation between caffeine concentration and phasic contractions in mesenteric arteries from DOCA hypertensive rats and shamtreated rats. Phasic contractions to caffeine in hypertensive arteries were not statistically different from normotensive values at any of the caffeine concentrations tested. Vascular sensitivity to caffeine in hypertensive arteries was not statistically different from that in normotensive arteries (DOCA, -log ED^ value=2.57±0.05 [antilog=2.66xlO~3 M]; sham, -log EDJO value=2.62±0.04 [antilog=2.43xlO"
3 M]). Variations in the calcium concentration (0.05-4 mM) during the loading period altered the magnitude of phasic contractions to caffeine (30 mM, Figure 5B ). Phasic contractions to caffeine in arteries from hypertensive rats did not differ from normotensive values at any of the calcium concentrations. ED50 values for calcium in arteries from hypertensive rats (-log EDso=3.51±0.07; antilog=3.07xlO" 4 M) were not statistically different from those in arteries from normotensive rats (-log ED 50 =3.53±0.03; antilog=2.93xHT 4 M). Phasic contractions to norepinephrine (5.9xl0~7 M) and caffeine (30 mM) in arteries without endo- thelium did not differ significantly from those in intact arteries. (Figure 6 ). The phasic contractions to norepinephrine, but not caffeine, in arteries from DOCA hypertensive rats were potentiated compared with normotensive values. The actions of several pharmacological agents were evaluated to provide insight into the cellular basis for enhanced phasic contractions to norepinephrine in arteries from DOCA hypertensive rats. All drugs were added at the beginning of the loading period in PSS with 2.0 mM CaCl 2 as described in Figure 1 . D-600, a calcium channel antagonist, did not influence phasic contractions to norepinephrine 8 (5.9xlCT 7 M) or caffeine (30 mM) in arteries from hypertensive or normotensive rats (Figure 7) . Ryanodine, a drug that causes a slow release of calcium from intracellular stores, 9 inhibited phasic contractions to norepinephrine and caffeine in arteries from hypertensive and normotensive rats. In contrast, NCDC, a phospholipase C inhibitor, 
mM CaCl 2 physiological salt solution (PSS). Strips were then depleted of calcium by placement in calcium-free PSS (1.0 mM EGTA) for 10 minutes. After this calcium depletion, strips were placed in 2.0 mM CaCl 2 PSS for 10 minutes. After the loading procedure, the strips were placed in calcium-free PSS (1.0 mM EGTA) for 1 minute and subsequently made to contract with caffeine (0.3-30 mM). Phasic contractions to caffeine in arteries from hypertensive rats did not differ from those in arteries from normotensive rats. Panel B: Mesenteric arteries were made to contract to caffeine (30 mM) in calcium-free PSS (1.0 mM EGTA) after incubation in PSS containing various concentrations of CaCl 2 (0.025-4.0 mM). Phasic responses to caffeine in arteries from hypertensive rats did not differ from normotensive values at any of the calcium concentrations tested. Values are mean±SEM for six rats in each group.
(4.6 xlO" 6 M to 2.2 xlO" 4 M) were added at the beginning of the loading period in PSS with 2.0 mM CaCl 2 as described in Figure 1 . In arteries from both normotensive and hypertensive rats, NCDC caused a concentration-dependent inhibition of phasic responses to norepinephrine (5.9xlO~7 M). Arteries from hypertensive rats were less sensitive to the inhibitory properties of NCDC than those from normotensive rats as indicated by the concentration of the drug that caused a half-maximal inhibition To determine the onset of changes in vascular responsiveness during the development of hypertension, phasic contractions to norepinephrine were examined in mesenteric arteries from rats that were treated with DOCA for 6 days. At this short interval, the systolic blood pressure of DOCA-treated rats was not significantly different from rats that were implanted with Silastic ( Figure 9A ). Phasic contractile responses to norepinephrine in arteries from 6 dayimplanted, DOCA-treated rats were not statistically different from normotensive values, and they were lower than those observed in arteries from rats that had been treated with the mineralocorticoid for 4-6 weeks.
In six experiments, the sodium sensitivity of the vascular change was examined by placing the rats on a low sodium intake at 4 weeks after implantation of the mineralocorticoid (Figure 9 ). Systolic blood pressures in DOCA-treated rats maintained on a low sodium diet for 2 weeks were not statistically different from normotensive values (low or high sodium diet; Figure 9A ). Phasic contractile responses to norepinephrine in arteries from DOCA-treated rats maintained on a low sodium diet did not differ significantly from normotensive values ( Figure 9B ).
Discussion
This study demonstrates that phasic contractile responses to norepinephrine in calcium-free solution are greater in mesenteric arteries from mineralocorticoid hypertensive rats than in those from normotensive rats. In contrast, caffeine-induced contractions in calcium-free buffer in hypertensive arteries did not differ from normotensive values. Removal of the endothelium from the vascular segments did not alter phasic contractions to norepinephrine or caffeine, indicating that the endothelium does not modulate the response under the conditions of our experiment. Based on pharmacological interventions with ryanodine and NCDC, it appears that enhanced responsiveness to norepinephrine in DOCA hypertension may be linked to an enhanced phosphoinositide signal rather than to a change in the size of an intracellular store for calcium.
The procedure used in this study to evaluate intracellular storage sites for calcium has been characterized previously.
-
811 Using rabbit aortic segments, Karaki and associates 8 demonstrated that the phasic response to norepinephrine is not blocked by organic and inorganic calcium channel blockers. The magnitude of the response to norepinephrine is dependent on 1) the concentration of added norepinephrine, 2) the duration of the unloading period, 3) the duration of incubation with calcium-containing buffer, and 4) the concentration of calcium used in the loading solution. The results of the current study confirm these observations. It appears that three of these experimental conditions do not provide an explanation for the enhanced norepinephrine responsiveness in DOCA hypertension. The concentration of calcium that was required for half-maximal responsiveness to norepinephrine in arteries from hypertensive rats did not differ from normotensive values (Figure 2) . Further, the time courses for calcium loading and depletion of the intracellular store in hypertensive arteries were not statistically different from those in arteries from normotensive arteries (Figure 3) . We conclude that under the conditions of our experiment, the hypertensive arteries load and release calcium from an intracellular store at about the same rate as in normotensive arteries. This is somewhat surprising based on the well-established observations that in hypertension, cell membrane permeability to calcium is increased and subcellular sequestration of calcium may be depressed (see Reference 12 for review). It may be that alterations in calcium extrusion mechanisms or intracellular buffering of the cation may have influenced the results. These possibilities do not seem very likely since caffeine-induced contractions in arteries from hypertensive rats did not differ from those in normotensive rats. Extensive experiments by other investigators 113 have documented that caffeine causes release of calcium from an intracellular store that is probably the sarcoplasmic reticulum. In our experiments, arteries that had been made to contract to caffeine in calcium-free medium could not subsequently be made to contract to norepinephrine (and vice versa). These observations suggest that both agonists use the same subcellular store of calcium to cause contraction.
The fourth possibility that relates to the concentration of norepinephrine provides a partial explanation for our results. In comparison with normotensive values, arteries from DOCA hypertensive rats were more sensitive to the contractile properties of norepinephrine as indicated by the leftward shift in EDso values (Figure 2) , and the magnitude of the phasic response was greater at all concentrations of the catecholamine. A possible explanation for these results is that there is an alteration in receptor binding or in the sequence of events following receptor activation in hypertensive arteries. Because the Ryanodine inhibited contractile responses to both norepinephrine and caffeine in arteries from hypertensive and normotensive rats. Other studies on vascular smooth muscle have documented that this plant alkaloid depletes calcium from intracellular stores rather than inhibit calcium release. 1 ' 313 The depletion occurs at a slow rate and thus ryanodine does not usually cause contraction since the released calcium is extruded through the plasma membrane by the calcium pump before build up of myoplasmic calcium occurs. This depletion reduces tension development in calcium-free buffer to subsequent stimuli that require the intracellular calcium store. Thus, we conclude that ryanodine depletes the store of calcium used by both norepinephrine and caffeine in rat mesenteric artery. It can also be concluded that the calcium release channels in mesenteric arteries of both hypertensive and normotensive rats are ryanodine-sensitive, suggesting that all are structurally similar.
NCDC, an inhibitor of phospholipase C, 510 inhibited contractions to norepinephrine but not those to caffeine in mesenteric arteries from both DOCA hypertensive and normotensive rats. Arteries from DOCA hypertensive rats were slightly less sensitive to the inhibitor than those from normotensive rats, as indicated by the concentration of NCDC that was required to inhibit half-maximally the phasic response to norepinephrine. Previous studies from this laboratory have demonstrated that this inhibitor reduces stimulusevoked accumulation of inositol phosphates in aortic smooth muscle and it inhibits phasic contractions to serotonin. 5 Because the accumulation of inositol phosphates is enhanced in hypertensive arteries, 15 - 18 we conclude that the augmented responsiveness to norepinephrine in DOCA hypertension reflects an alteration in the formation or metabolism of inositol phosphates, which serve as second messengers for calcium release from intracellular storage sites. Other investigators have reached a similar conclusion based on various experimental observations.
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- 18 An interesting observation of this study is that the change in vascular responsiveness to norepinephrine could be reversed by placing the DOCA-treated rats on a low sodium diet ( Figure 9) . Further, the change in responsiveness did not precede the development of high blood pressure, suggesting that the enhanced activity may reflect a secondary response to elevated blood pressure. Other investigators have also provided evidence that functional vascular changes in hypertension are dependent on dietary sodium and blood pressure (see Reference 12 for review).
It should be noted that the wall thickness of a vascular preparation influences its ability to respond to caffeine in calcium-free solution. Leijten and vanBreemen 19 observed that contractile responses to caffeine (10 mM) in rabbit aortic strips measuring 250 /Am in thickness were approximately 25% of the maximal response to norepinephrine. After removing a portion of the segment's wall so that its thickness measured approximately 100 fim, the contractile response to caffeine was about 60% of the response to norepinephrine. The authors concluded that as caffeine diffuses inwardly into thick preparations, the different layers of smooth muscle would be separately activated and inhibited, thereby preventing the summation of contraction by all smooth muscle cells in the arterial wall. Because arteries from hypertensive rats have a greater wall thickness than those from normotensive rats, 12 it is possible that caffeineinduced contractions were blunted due to a diffusion problem associated with the thicker wall. This seems unlikely, however, because the wall thickness (30-40 fim) of rat mesenteric arteries is considerably less than that of rabbit aortic strips, and thus the barrier for diffusion is less important. Additionally, in another model of rat hypertension (stroke-prone spontaneously hypertensive rat), we have observed that serotonin-and caffeine-induced contractions in aortic strips are both greater than those in aortic strips from normotensive rats. 20 Thus, it does not appear that the increased wall thickness characteristic of hypertension limits diffusion of caffeine to the extent that allows for an asynchrony of responsiveness in different layers of the vessel wall to the drug.
In summary, vascular responsiveness to norepinephrine but not caffeine is increased in mesenteric arteries from DOCA hypertensive rats. A high salt intake is necessary for this functional change, which does not precede the development of high blood pressure. This enhanced response to norepinephrine appears to reflect an alteration in phosphoinositide signaling rather than a change in intracellular storage of activator calcium.
